Početna stranicaSDZ • SWX
add
Sandoz Group AG
Preth. zaklj. cijena
48,25 CHF
Dnevni raspon
47,55 CHF - 48,25 CHF
Godišnji raspon
26,25 CHF - 50,88 CHF
Tržišna kapitalizacija
20,97 mlr. CHF
Prosječna količina
831,16 tis.
P/E omjer
116,00
Prinos dividende
1,25 %
Glavno tržište vrijednosnica
SWX
Vijesti s tržišta
CNBC
prije 20 sati
S&P 500 fights for another record — plus, Eaton signals big data center opportunity
0,048 %
1,62 %
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (USD) | lip 2025.info | Godišnja promjena |
|---|---|---|
Prihod | 2,63 mlr. | 4,01 % |
Operativni troškovi | 904,50 mil. | −11,67 % |
Neto dohodak | 188,50 mil. | 151,33 % |
Neto profitabilnost | 7,16 | 141,89 % |
Zarada po dionici | — | — |
EBITDA | 415,00 mil. | 53,42 % |
Efektivna porezna stopa | 25,20 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (USD) | lip 2025.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 1,39 mlr. | 98,15 % |
Ukupna imovina | 21,61 mlr. | 11,86 % |
Ukupne obveze | 12,79 mlr. | 16,79 % |
Ukupni kapital | 8,82 mlr. | — |
Dionice u optjecaju | 432,00 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 2,36 | — |
Povrat imovine | 3,48 % | — |
Povrat kapitala | 5,18 % | — |
Tok novca
Neto promjena novca
| (USD) | lip 2025.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 188,50 mil. | 151,33 % |
Gotovina od poslovanja | 261,50 mil. | 128,38 % |
Gotovina iz ulaganja | −158,00 mil. | 19,80 % |
Gotovina iz financiranja | −74,00 mil. | 35,09 % |
Neto promjena novca | 99,00 mil. | 148,53 % |
Slobodan tok novca | 151,94 mil. | 47,69 % |
Više
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkichen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Glavni izvršni direktor
Osnovano
1886
Web-lokacija
Zaposlenici
20.000
